The present invention described and shown in the specification and drawings provides novel recombinant DT-based immunotoxins, and, more specifically anti-T cell immunotoxin fusion proteins. Also provided are immunotoxins that can be expressed in bacterial, yeast, or mammalian cells. The invention also provides means for expression of the immunotoxin fusion protein.

 
Web www.patentalert.com

< Composition kits and methods for performing amplification reactions

> Bioinformatically detectable group of novel viral regulatory genes and uses thereof

> Expression of a recombinant transgene

~ 00597